Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site was updated from version v3.4.3 to v3.5.0. This release does not change the study content or user-facing information.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No other visible content changes were detected.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government-funding notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check58 days agoChange DetectedAdded a government funding lapse notice affecting site status and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedGlossary display has been added and the 'Last Update Submitted that Met QC Criteria' field is now shown. The 'No FEAR Act Data' notice has updated capitalization and the page revision changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This update does not modify study content, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.